• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ZER1 有助于高危型 HPV E7 蛋白的致癌活性。

ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

出版信息

mBio. 2022 Dec 20;13(6):e0203322. doi: 10.1128/mbio.02033-22. Epub 2022 Nov 8.

DOI:10.1128/mbio.02033-22
PMID:36346242
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9765665/
Abstract

Human papillomavirus (HPV) E7 proteins bind to host cell proteins to facilitate virus replication. Interactions between HPV E7 and host cell proteins can also drive cancer progression. We hypothesize that HPV E7-host protein interactions specific for high-risk E7 contribute to the carcinogenic activity of high-risk HPV. The cellular protein ZER1 interacts with the E7 protein from HPV16, the genotype most frequently associated with human cancers. The HPV16 E7-ZER1 interaction is unique among HPV E7 tested to date. Other E7 proteins, even from closely related HPV genotypes, do not bind ZER1, which is a substrate specificity factor for a CUL2-RING ubiquitin ligase. In the present study, we investigated the contribution of ZER1 to the carcinogenic activity of HPV16 E7. First, we mapped the ZER1 binding site to specific residues on the C terminus of HPV16 E7. We showed that the mutant HPV16 E7 that cannot bind ZER1 is impaired in the ability to promote the growth of primary keratinocytes. We found that ZER1 and CUL2 contribute to, but are not required for, HPV16 E7 to degrade RB1. Cancer dependency data show that ZER1 is an essential gene in most HPV-positive, but not HPV-negative, cancer cell lines. Depleting ZER1 impaired the growth of primary keratinocytes expressing HPV16 E7 or HPV18 E7 and of HPV16-and HPV18-positive cervical cancer cell lines. Taken together, our work demonstrates that ZER1 contributes to HPV-mediated carcinogenesis and is essential for the growth of HPV-positive cells. HPV16 is highly carcinogenic and is the most predominant HPV genotype associated with human cancers. The mechanisms that underlie differences between high-risk HPV genotypes are currently unknown, but many of these differences are likely attributable to the activities of the oncogenic HPV proteins, including E7. The HPV E7 oncoprotein is essential for HPV-mediated carcinogenesis. A large number of HPV E7 targets have been identified. However, it is unclear which of these many interactions contributes to the carcinogenic activity of HPV E7. Here, we characterized the interaction between HPV16 E7 and the host cell protein ZER1, testing whether this genotype-specific interaction could enable some of the carcinogenic activity of HPV16 E7. We found that ZER1 binding contributes to the growth-promoting activity of HPV16 E7 and to the growth of HPV-positive cervical cancer cells. We propose that ZER1 makes an important contribution to HPV-mediated carcinogenesis.

摘要

人乳头瘤病毒(HPV)E7 蛋白与宿主细胞蛋白结合,以促进病毒复制。HPV E7 与宿主细胞蛋白的相互作用也可推动癌症进展。我们假设,高危型 HPV E7 特有的 HPV E7-宿主蛋白相互作用有助于高危型 HPV 的致癌活性。细胞蛋白 ZER1 与 HPV16 的 E7 蛋白相互作用,HPV16 是与人类癌症最相关的基因型。在迄今为止测试的 HPV E7 中,HPV16 E7-ZER1 相互作用是独特的。其他 E7 蛋白,即使来自密切相关的 HPV 基因型,也不与 ZER1 结合,ZER1 是一种 CUL2-RING 泛素连接酶的底物特异性因子。在本研究中,我们研究了 ZER1 对 HPV16 E7 致癌活性的贡献。首先,我们将 ZER1 结合位点映射到 HPV16 E7 的 C 端的特定残基上。我们发现,不能与 ZER1 结合的 HPV16 E7 突变体在促进原代角质形成细胞生长的能力上受损。我们发现 ZER1 和 CUL2 有助于但不是必需的 HPV16 E7 降解 RB1。癌症依赖性数据表明,ZER1 是大多数 HPV 阳性但不是 HPV 阴性癌症细胞系中的必需基因。耗尽 ZER1 会损害表达 HPV16 E7 或 HPV18 E7 的原代角质形成细胞以及 HPV16 和 HPV18 阳性宫颈癌细胞系的生长。总之,我们的工作表明 ZER1 有助于 HPV 介导的致癌作用,并且是 HPV 阳性细胞生长所必需的。HPV16 具有高度致癌性,是与人类癌症最相关的主要 HPV 基因型。目前尚不清楚高危型 HPV 基因型之间差异的基础机制,但其中许多差异可能归因于致癌 HPV 蛋白的活性,包括 E7。HPV E7 癌蛋白是 HPV 介导的致癌作用所必需的。已经确定了大量 HPV E7 靶标。然而,尚不清楚这些相互作用中的哪一种有助于 HPV E7 的致癌活性。在这里,我们描述了 HPV16 E7 与宿主细胞蛋白 ZER1 之间的相互作用,检验了这种基因型特异性相互作用是否可以赋予 HPV16 E7 的部分致癌活性。我们发现 ZER1 结合有助于 HPV16 E7 的促生长活性和 HPV 阳性宫颈癌细胞的生长。我们提出 ZER1 对 HPV 介导的致癌作用有重要贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/12eb7ef0f312/mbio.02033-22-f009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/4b64351a67e2/mbio.02033-22-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/6cb323aedd1f/mbio.02033-22-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/b3a412f6ec15/mbio.02033-22-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/8a57c3786f7e/mbio.02033-22-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/0e14a50fdb25/mbio.02033-22-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/be05e7224e84/mbio.02033-22-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/a541cf0a2090/mbio.02033-22-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/8c9f4bc2f3b8/mbio.02033-22-f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/12eb7ef0f312/mbio.02033-22-f009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/4b64351a67e2/mbio.02033-22-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/6cb323aedd1f/mbio.02033-22-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/b3a412f6ec15/mbio.02033-22-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/8a57c3786f7e/mbio.02033-22-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/0e14a50fdb25/mbio.02033-22-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/be05e7224e84/mbio.02033-22-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/a541cf0a2090/mbio.02033-22-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/8c9f4bc2f3b8/mbio.02033-22-f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463b/9765665/12eb7ef0f312/mbio.02033-22-f009.jpg

相似文献

1
ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.ZER1 有助于高危型 HPV E7 蛋白的致癌活性。
mBio. 2022 Dec 20;13(6):e0203322. doi: 10.1128/mbio.02033-22. Epub 2022 Nov 8.
2
A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.人乳头瘤病毒 E7 蛋白 C 末端保守氨基酸残基介导其与 PTPN14 的结合并抑制上皮分化。
J Virol. 2020 Aug 17;94(17). doi: 10.1128/JVI.01024-20.
3
Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses.系统鉴定不同型别人类乳头瘤病毒宿主细胞蛋白与 E7 癌蛋白的相互作用。
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):E260-7. doi: 10.1073/pnas.1116776109. Epub 2012 Jan 9.
4
The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.膜相关泛素连接酶 MARCHF8 通过降解头颈部癌症中的 CUL1 和 UBE2L3 来稳定人乳头瘤病毒癌蛋白 E7。
J Virol. 2024 Feb 20;98(2):e0172623. doi: 10.1128/jvi.01726-23. Epub 2024 Jan 16.
5
Systematic Analysis of IL-1 Cytokine Signaling Suppression by HPV16 Oncoproteins.HPV16 致癌蛋白对 IL-1 细胞因子信号转导的系统分析。
J Virol. 2022 Nov 23;96(22):e0132622. doi: 10.1128/jvi.01326-22. Epub 2022 Nov 7.
6
CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.由CUL2/E2F1/miR-424调控环驱动的CUL2过表达促进HPV16 E7诱导的宫颈癌发生。
Oncotarget. 2016 May 24;7(21):31520-33. doi: 10.18632/oncotarget.9127.
7
Sustained expression of HPV16 E7 oncoprotein promotes p-AKT(Ser473)/p-Src(Tyr527) signaling to drive precancerous lesions to invasive cervical cancer.HPV16 E7 癌蛋白的持续表达促进 p-AKT(Ser473)/p-Src(Tyr527)信号转导,从而推动癌前病变发展为宫颈癌。
Carcinogenesis. 2022 Jun 4;43(5):479-493. doi: 10.1093/carcin/bgac010.
8
Repression of Memo1, a Novel Target of Human Papillomavirus Type 16 E7, Increases Cell Proliferation in Cervical Cancer Cells.抑制 HPV16 E7 的新型靶标 Memo1 可促进宫颈癌细胞增殖。
J Virol. 2022 Oct 26;96(20):e0122922. doi: 10.1128/jvi.01229-22. Epub 2022 Oct 5.
9
Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.锌指核酸酶靶向人乳头瘤病毒 E7 癌基因诱导 HPV16/18 阳性宫颈癌细胞中 E7 的破坏和转化表型。
Clin Cancer Res. 2014 Dec 15;20(24):6495-503. doi: 10.1158/1078-0432.CCR-14-0250. Epub 2014 Oct 21.
10
E6/E7 and E6 From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes.E6/E7 和 HPV16、HPV18 的 E6 上调角质形成细胞中的 IL-6 表达,与 p53 无关。
Front Immunol. 2019 Jul 23;10:1676. doi: 10.3389/fimmu.2019.01676. eCollection 2019.

引用本文的文献

1
Ubiquitin and ubiquitin-like proteins in HPV-driven carcinogenesis.人乳头瘤病毒驱动的致癌作用中的泛素和类泛素蛋白
Oncogene. 2025 Mar;44(11):713-723. doi: 10.1038/s41388-025-03310-6. Epub 2025 Feb 26.
2
The effect of phosphorylation efficiency on the oncogenic properties of the protein E7 from high-risk HPV.磷酸化效率对高危型 HPV 蛋白 E7 致癌特性的影响。
Virus Res. 2024 Oct;348:199446. doi: 10.1016/j.virusres.2024.199446. Epub 2024 Aug 14.
3
A replicative recombinant HPV16 E7 expression virus upregulates CD36 in C33A cells.

本文引用的文献

1
YAP1 activation by human papillomavirus E7 promotes basal cell identity in squamous epithelia.人乳头瘤病毒 E7 通过激活 YAP1 促进鳞状上皮的基底细胞特征。
Elife. 2022 Feb 16;11:e75466. doi: 10.7554/eLife.75466.
2
Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects.Chronos:一个用于 CRISPR 实验的细胞群体动力学模型,可提高基因适合度效应推断的准确性。
Genome Biol. 2021 Dec 20;22(1):343. doi: 10.1186/s13059-021-02540-7.
3
Molecular basis for recognition of Gly/N-degrons by CRL2 and CRL2.
一种复制性重组人乳头瘤病毒16型E7表达病毒上调C33A细胞中的CD36。
Front Microbiol. 2023 Aug 30;14:1259510. doi: 10.3389/fmicb.2023.1259510. eCollection 2023.
Gly/N-去稳定基序被 CRL2 和 CRL2. 识别的分子基础
Mol Cell. 2021 Aug 19;81(16):3262-3274.e3. doi: 10.1016/j.molcel.2021.06.010. Epub 2021 Jul 1.
4
Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia.肠道病毒 3C 蛋白酶在气道上皮细胞中激活人类 NLRP1 炎性小体。
Science. 2020 Dec 4;370(6521). doi: 10.1126/science.aay2002. Epub 2020 Oct 22.
5
A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.人乳头瘤病毒相关性头颈部癌症的最新研究进展。
Viruses. 2019 Oct 9;11(10):922. doi: 10.3390/v11100922.
6
Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus.HPV 致癌蛋白 E7 识别肿瘤抑制蛋白 PTPN14 的结构基础。
PLoS Biol. 2019 Jul 19;17(7):e3000367. doi: 10.1371/journal.pbio.3000367. eCollection 2019 Jul.
7
A glycine-specific N-degron pathway mediates the quality control of protein -myristoylation.甘氨酸特异性 N 肽段途径介导蛋白质 - 豆蔻酰化的质量控制。
Science. 2019 Jul 5;365(6448). doi: 10.1126/science.aaw4912.
8
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.利用 CRISPR-Cas9 筛选技术对癌症治疗靶点进行优先级排序。
Nature. 2019 Apr;568(7753):511-516. doi: 10.1038/s41586-019-1103-9. Epub 2019 Apr 10.
9
PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.高危型人乳头瘤病毒 E7 通过降解 PTPN14 抑制角质形成细胞分化并促进 HPV 介导的肿瘤发生。
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7033-7042. doi: 10.1073/pnas.1819534116. Epub 2019 Mar 20.
10
The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.人乳头瘤病毒复制周期及其与癌症进展的关联:全面综述
Clin Sci (Lond). 2017 Aug 10;131(17):2201-2221. doi: 10.1042/CS20160786. Print 2017 Sep 1.